MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-01-2024
Bausch Health Companies DPO Ratio 2011-2026 | BHC
Annual DPO Ratio Bausch Health Companies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 78.1 | 63.8 | 52.3 | 45.3 | 61.2 | 64.4 | 62.6 | 79.9 | 79.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 79.9 | 45.3 | 65.2 |
DPO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
38 | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
519 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
75.6 | - | -39.89 % | $ 27.7 M | USA |
 |
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | USA |
 |
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
5.36 K | - | - | $ 36.6 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
224 | - | - | $ 2.06 B |  France |
 |
Cumberland Pharmaceuticals
CPIX
|
775 | $ 3.18 | 1.92 % | $ 44.7 M | USA |
 |
Cronos Group
CRON
|
212 | $ 2.57 | - | $ 1.33 B |  Canada |
 |
Jupiter Wellness
JUPW
|
318 | - | - | $ 33.6 M | USA |
 |
Harrow Health
HROW
|
199 | $ 37.94 | 2.27 % | $ 1.39 B | USA |
 |
Aurora Cannabis
ACB
|
-807 | $ 3.53 | 1.44 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
52.8 | $ 1.09 | 0.93 % | $ 117 M | Canada |
 |
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
59.4 | $ 4.44 | 2.54 % | $ 286 M | USA |
 |
Emergent BioSolutions
EBS
|
55.8 | $ 8.66 | 5.1 % | $ 443 M | USA |
 |
Organogenesis Holdings
ORGO
|
94 | $ 2.51 | 5.46 % | $ 330 M | USA |
 |
Pacira BioSciences
PCRX
|
37.3 | $ 23.75 | -1.29 % | $ 1.1 B | USA |
 |
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | USA |
 |
ProPhase Labs
PRPH
|
45.4 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
122 | $ 18.02 | - | $ 115 M | USA |
 |
Radius Health
RDUS
|
274 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
194 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
20.2 | $ 1.02 | 0.99 % | $ 50.9 M | USA |
 |
Tilray
TLRY
|
53 | $ 6.91 | 2.83 % | $ 4.27 B | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
32.3 | $ 2.18 | -7.23 % | $ 2.71 M | USA |
 |
Veru
VERU
|
264 | $ 2.42 | 1.68 % | $ 326 M | USA |
 |
Viatris
VTRS
|
64 | $ 13.91 | 0.58 % | $ 16.7 B | USA |
 |
cbdMD
YCBD
|
84 | $ 0.73 | -2.28 % | $ 3.15 M | USA |
 |
Zomedica Corp.
ZOM
|
64.3 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
15.4 | $ 0.93 | -1.38 % | $ 33.5 M | USA |
 |
China Pharma Holdings
CPHI
|
47.6 | $ 0.63 | -3.05 % | $ 2.7 M |  China |
 |
TherapeuticsMD
TXMD
|
723 | $ 2.11 | 2.93 % | $ 24.4 M | USA |